Making financial sacrifices during treatment can have long-term effects on survivorship for patients with cancer, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Making financial sacrifices during treatment can have long-term effects on survivorship for patients with cancer, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Transcript
In your research, have you discovered trends that indicate which patients fare better after active cancer treatment is completed?
So, in my own research what I focus on often is the experience of cancer patients [who] have comorbid conditions. Also, I’ve done some work with longer-term survivors, and with longer-term survivors, [those] patients who have perceived to have had to make a financial sacrifice during the acute treatment experience can have longer term experiences of distress, psychological distress. So, I think the impact [on] finances at the acute phase can have a really enduring effect on someone’s experience over the long term.
Are payers doing enough to ensure that cancer survivors receive appropriate follow up care, and if not what needs to change?
So, I think that currently the evidence in survivorship is evolving as the population of cancer survivors is growing. I think that as more information is developed about risk stratifications, so which patients have the most complex long-term sequelae. Payers can really incentive providers coordinating that care and providing that care in a way that’s efficient but also effective, and I think that is improving the information evidence is improving over time and I think payers can incentive putting that evidence into practice.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More